Review of Significant Evaluations


In the spring of 1992, 124 individuals experiencing a variety of chronic or recurring conditions were provided with a quantity of Cytolog adequate for a two week period. Responses were recorded in the following manner:

The results of the two week study are outlined below.
Reporting
Condition
(0)
(1)
(2)
(3)
Inconclusive
58
Arthritis
14
5
12
17
9
21
Allergies
3
4
3
1
10
Celiac Sprue
1
2
6
1
9
Hypertension
1
4
3
1
5
Endometriosis 3
2
5
Psoriasis
1
1
3
4
Colds
4
4
Premenstrual Syndrome
4
3
Prostatitis/BHP
3
1
Herpes Simplex 1
1
1
Lupus (Discoid)
1
1
Sarcoidosis
1
1
Perthes Disease
1
1
Sjogren's Syndrome
1

(Experience has since shown that taking Cytolog Infopeptides for 30 days typically produces even more dramatic results)

Immediately following this initial study, Dr. M S, MD in California, while directing certain portions of the invitro investigations, had the opportunity to provide the product to two patients in Washington State (USA) that suffered from Celiac disease. In both cases the diagnosis had been confirmed by biopsy. After four days of supplementation with Cytolog Infopeptides, both patients began to consume normal diets without any evidence of intolerance. After six weeks blood taken from both individuals was submitted to V. J. Ph.D. in New York (USA) and found to be negative to all four antibody tests. Dr. K's comments were:

"These negative tests for IgA class endomysial antibodies and IgA class antibodies to reticulin and normal levels for IgG and IgA class antibodies to gliadin, when taken together are not suggestive of a diagnosis of Celiac Disease."

(Doctor's full names have been abbreviated for privacy)


Previous Page
Legal Information
Site Directory
Next Page

©2006 Lifestar... the art of healing. Cytolog™ and Infopeptide™ are trademarks of Cellogic Corporation. All rights reserved.